Ledger.Open graph →
SEC Form D · filed May 13, 2024

Ajax Therapeutics, Inc

Offering
$95.0M
Sold
$95.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Martin Vogelbaum · New York, NYExec · DirectorRamy Farid · New York, NYDirectorRoss Levine · New York, NYDirectorScott Platshon · New York, NYDirectorMan E. Kinoshita · New York, NYDirectorStephen (. Hipp · New York, NYExec · DirectorHallbjorn Karlsson · New York, NYDirectorJeremy G. Wiltshire · New York, NYDirectorTim S. Spengler · West Hollywood, CAExec · DirectorMichael S. Zemetra · West Hollywood, CADirectorRobert S. Ellin · West Hollywood, CADirectorRobert Belcher · Cincinnati, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗